Control of an outbreak of an epidemic methicillin-resistant Staphylococcus aureus also resistant to mupirocin

Journal of Hospital Infection

Volumn 39, Issue 1, 1998, Pages 19-26

  Irish, D ^a   Eltringham, I ^a   Teall, A ^a   Pickett, H ^a   Farelly, H ^b   Reith, S ^b   Woodford, N ^b   Cookson, B ^b  

^a Department of Microbiology Greenwich Hospital   (United Kingdom)

^b CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

Author keywords

MRSA; Mupirocin resistance; Outbreak control

Indexed keywords

ANTIBIOTIC AGENT; BACITRACIN; CIPROFLOXACIN; FUSIDIC ACID; PSEUDOMONIC ACID; RIFAMPICIN; TRICLOSAN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIOPHAGE TYPING; CLINICAL ARTICLE; EPIDEMIC; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INTRANASAL DRUG ADMINISTRATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; ORAL DRUG ADMINISTRATION; PLASMID; PRACTICE GUIDELINE; PULSED FIELD GEL ELECTROPHORESIS; STAFF; STAPHYLOCOCCUS INFECTION; TOPICAL DRUG ADMINISTRATION;

EID: 0031747671     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-6701(98)90239-0     Document Type: Article

References (13)

1. Kerr S, Kerr GE, Mackintosh CA, Marples RR. A survey of methicillin-resistant Staphylococcus aureus affecting patients in England and Wales. J Hosp Infect 1990; 16: 35-48.
2. Ayliffe GAJ, Brumfitt W, Casewell MW, Cookson BD, Duckworth G et al. Revised guidelines for the control of epidemic methicillin-resistant Staphylococcus aureus. J Hosp Infect 1990; 16: 351-377.
3. Rahman M, Noble WC, Cookson BD. Mupirocin-resistant Staphylococcus aureus. Lancet 1987; ii: 387.
4. Cookson BD, Farrelly HD, Stapleton P, Garvey RPJ, Price MR. Transferable resistance to triclosan in MRSA. Lancet 1991; ii: 1548-1549.
5. Cookson BD, Palepou M-F, George RC, Farrelly HD. Mupirocin-resistant Staphylococcus aureus. Lancet 1992; i: 625.
6. Cookson BD, Aparicio P, Deplanoi A, Struelens M, Goering R, Marples RR. Inter-centre comparison of pulsed field gel electrophoresis for the typing of methicillin resistant Staphylococcus aureus. J Med Microbiol 1996; 44: 179-184.
7. Rahman M, Connely S, Noble WC, Cookson BD, Phillips I. The diversity of staphylococci exhibiting high-level resistance to mupirocin. J Med Microbiol 1990; 33: 97-100.
8. Woodford N, Watson AP, Patel S, Waghorn DJ, Cookson BD. Heterogeneous location of the novel mupA gene which confers high-level mupirocin resistance in Staphylococcus aureus. J Med Microbiol (in press).
9. Cookson BD, Phillips I. Methicillin-resistant staphylococci. J Appl Bacteriol 1990; 69; Suppl 19: 55-70.
10. Hudson IRB. The efficacy of intranasal mupirocin in the prevention of staphylococcal infections: a review of recent experience. J Hosp Infect 1994; 27: 81-98.
11. Layton MC, Perez M, Heald P, Patterson JE. An outbreak of mupirocin-resistant Staphylococcus aureus on a dermatology ward associated with an environmental reservoir. Infect Control Hosp 1993; 14: 369-375.
12. Dawson SJ, Finn LF, McCulloch JE, Kilvington S, Lewis DA. Mupirocin-resistant MRSA. J Hosp Infect 1994; 28: 75-78.
13. Marples RR, Speller DCE, Cookson BD. Prevalence of mupirocin resistance in Staphylococcus aureus. J Hosp Infect 1995; 29: 153-161.